HYPONATREMIA IN COVID-19 PATIENTS

Sponsor
Hospital Nacional Profesor Alejandro Posadas (Other)
Overall Status
Completed
CT.gov ID
NCT04493268
Collaborator
(none)
250
1
4.5
56

Study Details

Study Description

Brief Summary

SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    250 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    HYPONATREMIA AND INFLAMMATION AND CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS
    Actual Study Start Date :
    Mar 7, 2020
    Actual Primary Completion Date :
    Jul 20, 2020
    Actual Study Completion Date :
    Jul 21, 2020

    Outcome Measures

    Primary Outcome Measures

    1. MORTALITY [30 DAYS]

      HYPONATREMIA AND MORTALITY

    Secondary Outcome Measures

    1. ICU HOSPITALIZATION [30 DAYS]

      HYPONATREMIA AND ICU HOSPITALIZATION

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 100 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • PATIENTS WITH SARS-CoV-2 INFECTION CONFIRMED BY PCR OF NASOPHARYNGEAL SWABS.
    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Posadas Buenos Aires Argentina 1684

    Sponsors and Collaborators

    • Hospital Nacional Profesor Alejandro Posadas

    Investigators

    • Principal Investigator: CARLOS EGHI, physician, University of Buenos Aires

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ladislao Diaz Ballve, GRADUATE IN KINESIOLOGY, Hospital Nacional Profesor Alejandro Posadas
    ClinicalTrials.gov Identifier:
    NCT04493268
    Other Study ID Numbers:
    • HYPONATREMIA IN COVID PATIENTS
    First Posted:
    Jul 30, 2020
    Last Update Posted:
    Jul 30, 2020
    Last Verified:
    Jul 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ladislao Diaz Ballve, GRADUATE IN KINESIOLOGY, Hospital Nacional Profesor Alejandro Posadas
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 30, 2020